Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials

by Fang-Shu Ou, Jun Tang, Ming-Wen An, Sumithra J. Mandrekar
Published 2021-09-01

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials

by Ming-Wen An, Jun Tang, Axel Grothey, Daniel J. Sargent, Fang-Shu Ou, Sumithra J. Mandrekar
Published 2020-03-01

A suggested approach for imputation of missing dietary data for young children in daycare

by June Stevens, Fang-Shu Ou, Kimberly P. Truesdale, Donglin Zeng, Amber E. Vaughn, Charlotte Pratt, Dianne S. Ward
Published 2015-12-01

Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer

by Edoardo Francini, Fang-Shu Ou, Justin Rhoades, Eric G. Wolfe, Edward P. O’Connor, Gavin Ha, Gregory Gydush, Kaitlin M. Kelleher, Rupal S. Bhatt, Steven P. Balk, Christopher J. Sweeney, Viktor A. Adalsteinsson, Mary-Ellen Taplin, Atish D. Choudhury
Published 2021-08-01

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study

by Edoardo Francini, Fang-Shu Ou, Stefano Lazzi, Roberto Petrioli, Andrea G. Multari, Guido Pesola, Luciana Messuti, Elena Colombo, Virginia Livellara, Serena Bazzurri, Sara Cherri, Salvatora T. Miano, Eric G. Wolfe, Steven R. Alberts, Joleen M. Hubbard, Harry H. Yoon, Guido Francini
Published 2021-02-01

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resect...

by Matthew H. G. Katz, Fang-Shu Ou, Joseph M. Herman, Syed A. Ahmad, Brian Wolpin, Robert Marsh, Spencer Behr, Qian Shi, Michael Chuong, Lawrence H. Schwartz, Wendy Frankel, Eric Collisson, Eugene J. Koay, JoLeen M. Hubbard, James L. Leenstra, Jeffrey Meyerhardt, Eileen O’Reilly, for the Alliance for Clinical Trials on Oncology
Published 2017-07-01